"The University of Arizona Cancer Center is designated by the National Cancer Institute (NCI) as a Comprehensive Cancer Center. This designation, the NCI’s highest, is reserved for centers focusing on patient care, research, prevention, education, outreach and training."

During the past decade, University of Arizona Cancer Center-North Campus conducted 118 clinical trials. In the 10-year time frame, 118 clinical trials started and 60 clinical trials were completed, i.e. on average, 50.8% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 38 clinical trials were completed. i.e. 90.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Arizona Cancer Center-North Campus" #1 sponsor was "National Cancer Institute (NCI)" with 77 trials, followed by "SWOG Cancer Research Network" with 33 trials sponsored, "NRG Oncology" with 12 trials sponsored, "Gynecologic Oncology Group" with 10 trials sponsored and "Alliance for Clinical Trials in Oncology" with 10 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Arizona Cancer Center-North Campus" #1 collaborator was "National Cancer Institute (NCI)" with 80 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 2 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "University of Arizona Cancer Center-North Campus" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Breast Cancer" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Acute Myeloid Leukemia" (5 trials) and "Colorectal Cancer" (5 trials). Many other conditions were trialed in "University of Arizona Cancer Center-North Campus" in a lesser frequency.

Most popular intervention types in "University of Arizona Cancer Center-North Campus" are "Drug" (141 trials), "Other" (104 trials), "Biological" (64 trials), "Procedure" (54 trials) and "Radiation" (37 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (48 trials), "Quality-of-Life Assessment" (36 trials), "Questionnaire Administration" (26 trials), "Carboplatin" (21 trials) and "Biospecimen Collection" (19 trials). Other intervention names were less common.

The vast majority of trials in "University of Arizona Cancer Center-North Campus" are 134 trials for "All" genders, 34 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "University of Arizona Cancer Center-North Campus". undefined are not yet recruiting, 51 are recruiting, 69 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in University of Arizona Cancer Center-North Campus, 4 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in University of Arizona Cancer Center-North Campus, 21 "Phase 1" clinical trials were conducted, 86 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".